30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Zimmer Biomet Responds to FDA Form 483 -

Zimmer Biomet published a response to the Form 483 issued by FDA in April 2018, related to inspectional observations at the Warsaw North Campus manufacturing facility. The company reiterated that none of the observations identified specific performance issues with particular products, and that all products continue to be manufactured in the facility. (Zimmer Biomet, Inc., 6/25/18)